tiprankstipranks
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
GPCR
Structure Therapeutics, Inc. Sponsored ADR
RESEARCH TOOLSreports

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Stock News & Sentiment

1,243 Followers
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
Premium
Ratings
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
24d ago
GPCR
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
Premium
Ratings
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
25d ago
GPCR
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
Premium
Company Announcements
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
25d ago
8K
GPCR
Leveraging External Amylin Validation: Positioning Structure Therapeutics’ Amylin and Oral GLP‑1 Platform for Combination-Driven Upside
Premium
Ratings
Leveraging External Amylin Validation: Positioning Structure Therapeutics’ Amylin and Oral GLP‑1 Platform for Combination-Driven Upside
1M ago
GPCR
Buy Rating on Structure Therapeutics: Strong Phase II Data and Upcoming Late‑Stage Catalysts Support Upside for Oral GLP‑1 Aleniglipron
Premium
Ratings
Buy Rating on Structure Therapeutics: Strong Phase II Data and Upcoming Late‑Stage Catalysts Support Upside for Oral GLP‑1 Aleniglipron
1M ago
GPCR
Validating IP, Extending Runway: Why Structure Therapeutics’ Oral GLP‑1 Platform Supports a Buy Rating
Premium
Ratings
Validating IP, Extending Runway: Why Structure Therapeutics’ Oral GLP‑1 Platform Supports a Buy Rating
3M ago
GPCR
Structure Therapeutics inks major GLP-1 licensing deal
Premium
Company Announcements
Structure Therapeutics inks major GLP-1 licensing deal
3M ago
8K
GPCR
More GPCR News >

GPCR News on the Web

Why Structure Therapeutics Stock Is Suddenly Sinking
TipRanks News
Bearish
Why Structure Therapeutics Shares Are Sliding Today
TipRanks News
Bearish
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval
Zacks
Neutral
Why Structure Therapeutics Stock Suddenly Took Off Today
TipRanks News
Bullish
Why Structure Therapeutics Stock Is Suddenly Surging
TipRanks News
Bullish
LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill?
Zacks
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison
CNBC
Neutral

News Score - Last 7 Days

Negative
GPCR
Sector Average
Media Buzz
This Week5 articles
Weekly Average8.75 articles
News Sentiment
This Week33%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GPCR’s Media Buzz Sentiment?
5 articles about GPCR were published this week. In an average week, 8.75 articles are published.
    What is GPCR’s weekly average amount of articles?
    In an average week, 8.75 articles about GPCR are published.
      What is GPCR’s News Sentiment?
      33% of articles about GPCR were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        OWLTOwlet
        STAAStaar Surgical
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week